Galera Therapeutics, Inc.
Ticker: GRTX
| Insider | Title |
|---|---|
| Chris Degnan | Chief Financial Officer |
| Emmett Cunningham | Director |
| Eugene P. Kennedy | Chief Medical Officer |
| Jennifer Evans Stacey | See Remarks |
| Jon T Holmlund | Chief Medical Officer |
| Kevin G Lokay | Director |
| Lawrence M Alleva | Director |
| Linda West | Director |
| Mark Bachleda | Chief Commercial Officer |
| Mark E. Pearson | See footnote 1 below |
| Mel Sorensen | President and CEO, Director |
| Michael Powell | Director |
| Pharma Investments Llc Alpha | 10% or greater ownership |
| Pharmaceutical Holdings, Llc Altamont | 10% or greater ownership |
| Robert A Beardsley | Chief Operating Officer |
| Rochel Soffer | 10% or greater ownership |
| Yair Schneid | 10% or greater ownership |